0001140361-15-032968.txt : 20150820 0001140361-15-032968.hdr.sgml : 20150820 20150820165142 ACCESSION NUMBER: 0001140361-15-032968 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150820 DATE AS OF CHANGE: 20150820 EFFECTIVENESS DATE: 20150820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chase Pharmaceuticals Corp CENTRAL INDEX KEY: 0001509008 IRS NUMBER: 208866868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-246193 FILM NUMBER: 151066743 BUSINESS ADDRESS: STREET 1: 1823 K STREET, NW STREET 2: SUITE 520 CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: 202-223-7002 MAIL ADDRESS: STREET 1: 1823 K STREET, NW STREET 2: SUITE 520 CITY: WASHINGTON STATE: DC ZIP: 20006 D 1 primary_doc.xml X0707 D LIVE 0001509008 Chase Pharmaceuticals Corp 1823 K STREET, NW SUITE 520 WASHINGTON DC DISTRICT OF COLUMBIA 20006 202-223-7002 DELAWARE None None Corporation true John M. Siebert c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Executive Officer Thomas N. Chase c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Executive Officer Director Kathleen Clarence-Smith c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Executive Officer Stephen Cunningham c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Director Karoly Nikolich c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Director N. Greg Parekh c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Director John M. Reher c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Director Vikram Sudarsan c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Director Raphael Wisniewski c/o Chase Pharmaceuticals Corporation 1825 K Street, NW Suite 520 Washington DC DISTRICT OF COLUMBIA 20006 Director Pharmaceuticals Decline to Disclose 06b false 2015-08-05 false true true true false 0 3000000 3000000 0 This filing covers the sale and issuance of Series B-1A Preferred Stock, the Common Stock issuable upon conversion thereof and the sale and issuance of Warrants exercisable for Series B-1A Preferred Stock. false 12 0 0 0 false Chase Pharmaceuticals Corp /s/ John M. Siebert John M. Siebert, Ph.D. Chief Executive Officer 2015-08-19